期刊文献+
共找到9篇文章
< 1 >
每页显示 20 50 100
甲状腺功能亢进症患者血清胎球蛋白A水平与胰岛素抵抗相关性研究 被引量:12
1
作者 王炜城 杨琼 《检验医学》 CAS 2019年第10期901-904,共4页
目的探讨甲状腺功能亢进症(简称甲亢)患者血清胎球蛋白A水平与胰岛素抵抗(IR)的关系。方法选取采用卡比马唑治疗的甲亢患者60例,所有患者均治愈。以体检健康者60名作为正常对照组。收集所有对象的一般资料(年龄、性别、身高、体质量等)... 目的探讨甲状腺功能亢进症(简称甲亢)患者血清胎球蛋白A水平与胰岛素抵抗(IR)的关系。方法选取采用卡比马唑治疗的甲亢患者60例,所有患者均治愈。以体检健康者60名作为正常对照组。收集所有对象的一般资料(年龄、性别、身高、体质量等),检测甲亢组治疗前后及正常对照组胎球蛋白A、促甲状腺激素(TSH)、游离三碘甲状腺原氨酸(FT3)、游离甲状腺素(FT4)、胰岛素、C反应蛋白(CRP)、血钙、血糖水平。采用Pearson相关分析评估胎球蛋白A与各项指标之间的相关性。结果甲亢组治疗前体质量指数(BMI)、TSH明显低于治疗后及正常对照组(P<0.05),FT3、FT4、血钙、CRP、胰岛素抵抗指数(HOMA-IR)、胎球蛋白A明显高于治疗后及正常对照组(P<0.05)。甲亢组治疗后BMI、TSH、FT3、FT4、血钙、CRP、胎球蛋白A与正常对照组比较差异均无统计学意义(P>0.05),而HOMA-IR明显高于正常对照组(P<0.05)。甲亢患者治疗前、后血清胎球蛋白A与FT3、FT4、CRP、HOMA-IR均呈正相关(P<0.05),与TSH均呈负相关(P<0.05),与BMI、血钙均无相关性(P>0.05)。结论甲亢患者血清胎球蛋白A水平升高,可能与IR有关。 展开更多
关键词 胎球蛋白A 甲状腺功能亢进症 胰岛素抵抗 卡比马唑
下载PDF
抗甲状腺药物所致肝损伤的研究进展 被引量:1
2
作者 黄倩 方坚 +2 位作者 阮梅 夏磊 李东良 《药物评价研究》 CAS 北大核心 2024年第5期927-932,共6页
药物治疗是甲状腺功能亢进的主要治疗方法,常用的抗甲状腺药物包括丙基硫氧嘧啶、甲巯咪唑及其前体药物卡比马唑。这些抗甲状腺药物可引起不同程度的肝损伤。虽然对抗甲状腺药物导致肝毒性的认识已超过70年,但是近年来仍有一些新的报道... 药物治疗是甲状腺功能亢进的主要治疗方法,常用的抗甲状腺药物包括丙基硫氧嘧啶、甲巯咪唑及其前体药物卡比马唑。这些抗甲状腺药物可引起不同程度的肝损伤。虽然对抗甲状腺药物导致肝毒性的认识已超过70年,但是近年来仍有一些新的报道和阐述。对常见抗甲状腺药物导致肝损伤的发生率、临床病理特点、作用机制以及预防等方面的研究进展进行综述和分析,为临床安全、合理用药提供参考。 展开更多
关键词 甲状腺功能亢进症 抗甲状腺药物 药物性肝损伤 甲巯咪唑 卡比马唑 丙基硫氧嘧啶
原文传递
母孕期使用抗甲状腺药物对后代先天畸形发生风险的Meta分析 被引量:4
3
作者 颜莉 余春飞 +1 位作者 郑天银 刘彬 《中国新药与临床杂志》 CAS CSCD 北大核心 2018年第11期628-639,共12页
目的探讨母孕期使用抗甲状腺药物对后代先天畸形发生风险的影响。方法检索PubMed、EMBASE、 Cochrane Library、 Ovid、中国知网、维普和万方等数据库中关于母孕期使用抗甲状腺药物对后代先天畸形风险的相关研究,检索时限均为从建库起至... 目的探讨母孕期使用抗甲状腺药物对后代先天畸形发生风险的影响。方法检索PubMed、EMBASE、 Cochrane Library、 Ovid、中国知网、维普和万方等数据库中关于母孕期使用抗甲状腺药物对后代先天畸形风险的相关研究,检索时限均为从建库起至2018年4月1日。采用RevMan 5.3软件进行Meta分析,探讨两者之间的关系。结果共纳入15项研究, 21 167名孕妇在孕期使用不同的抗甲状腺药物, Meta分析结果显示,甲亢孕妇妊娠早期使用抗甲状腺药物[甲巯咪唑(MMI)/卡比马唑(CMZ)或丙硫氧嘧啶(PTU)或MMI/CMZ+PTU](暴露组)均比无甲亢孕妇(对照组)及妊娠期未使用抗甲状腺药物的甲亢孕妇(未用药组)后代的先天畸形风险明显升高(P <0.05); MMI/CMZ组后代发生先天畸形的风险显著高于PTU组(P <0.05); MMI/CMZ+PTU组与MMI/CMZ组、 PTU组相比,后代发生先天畸形的风险无显著差异(P≥0.05)。结论妊娠期甲亢患者使用抗甲状腺药物会使后代发生先天畸形的风险升高,应权衡利弊,谨慎用药。 展开更多
关键词 甲状腺功能亢进症 妊娠并发症 甲巯咪唑 卡比马唑 丙硫氧嘧啶 先天畸形 META分析
原文传递
Carbimazole Drug-Induced Hepatitis during Treatment of Graves’ Disease: About Four Cases at Dakar Teaching Hospital
4
作者 Abdoulaye Leye Michel Assane Ndour +3 位作者 Nafy Ndiaye Sarr Ngoné Diaba Diack Yakham Mohamed Leye Dominique Emmanuel Faye 《Open Journal of Internal Medicine》 2017年第4期97-104,共8页
Introduction: Mostly reported common side effects of carbimazole are cutaneous allergies and severe agranulocytosis. However, hepatotoxicity is rarely described. Thus, we report four observations of carbimazole drug-i... Introduction: Mostly reported common side effects of carbimazole are cutaneous allergies and severe agranulocytosis. However, hepatotoxicity is rarely described. Thus, we report four observations of carbimazole drug-induced hepatitis during the treatment of Graves’ disease, which imputability is likely and probably an immuno-allergic mechanism. Observations: They were four women whose average age was 43 years, with extreme ages of 32 and 54. Patients were monitored and treated with carbimazole in doses contained between 40 mg and 60 mg per day. Clinical manifestations of liver injury were mainly dominated by cholestatic jaundice, found in 100% of our patients. A painful sensitivity of the right hypochondrium was concomitant with jaundice for two patients. The jaundice time to onset after the beginning of treatment with carbimazole varies between 1 month and 6 months. They all had acute hepatitis. The biological assays used to determine the type of liver injury showed, in all cases, a mixed, cholestatic and cytolytic hepatitis. Therapeutically, in all patients, carbimazole was stopped as soon as the suspicion of its incrimination in the occurrence of liver damage was set up. They all had a substitution of carbimazole with benzylthiouracil. Evolution was favorable for all patients, after therapeutic substitution. It was marked by disappearance of jaundice and normalization of the liver biological parameters within a maximum delay of two months after stopping carbimazole use. Conclusion: Treatment with synthetic antithyroid drugs, particularly carbimazole that is most widely used in our regions, requires clinical and biological monitoring. This surveillance, which is often difficult in Africa because of the limited economic resources, can lead to the occurrence of side effects such as potentially serious drug-induced hepatitis, but which has been favorable in our observations. 展开更多
关键词 DRUG-INDUCED HEPATITIS carbimazole Graves’ Disease
下载PDF
以铁氰化钾为探针试剂光度法测定卡比马唑 被引量:1
5
作者 郭丽 刘礼涛 张丹 《广州化工》 CAS 2016年第14期152-155,共4页
采用K_3[Fe(CN)_6]为探针试剂分光光度法测定卡比马唑的新方法。研究表明,在酸性条件下,卡比马唑使Fe(III)还原为Fe(II),还原生成的Fe(II)可以与K_3[Fe(CN)_6]反应生成可溶性普鲁士蓝KFeIII[FeII(CN)6]。卡比马唑的浓度在0.... 采用K_3[Fe(CN)_6]为探针试剂分光光度法测定卡比马唑的新方法。研究表明,在酸性条件下,卡比马唑使Fe(III)还原为Fe(II),还原生成的Fe(II)可以与K_3[Fe(CN)_6]反应生成可溶性普鲁士蓝KFeIII[FeII(CN)6]。卡比马唑的浓度在0.05~4.8μg/m L范围内与吸光度呈现良好线性关系,线性回归方程A=0.02016+0.35987C(μg/m L),相关系数R=0.9998,检出限为0.042μg/m L,相对标准偏差R.S.D.=0.58%(n=11),间接测定卡比马唑的摩尔吸光系数ε=6.7×105L/(mol·cm-1)。本方法成功用于药物中卡比马唑含量的测定,平均回收率为98.3%~102.0%,结果满意。 展开更多
关键词 卡比马唑 铁氰化钾 分光光度法
下载PDF
Impact of ginger aqueous extract on carbimazole induced testicular degenerative alterations and oxidative stress in albino rats 被引量:1
6
作者 Saber Abdel-Rahman Sakr Sobhy Elsaid Hassab ELnaby +1 位作者 Yosry Aly Okdah Ahmed Mohamed El-Shabka 《Journal of Coastal Life Medicine》 CAS 2017年第4期167-173,共7页
Objective: To evaluate the effect of ginger (Zingiber officinale) aqueous extract, a natural herb, with antioxidant properties, on testicular toxicity and oxidative stress induced by the antithyroid drug carbimazole i... Objective: To evaluate the effect of ginger (Zingiber officinale) aqueous extract, a natural herb, with antioxidant properties, on testicular toxicity and oxidative stress induced by the antithyroid drug carbimazole in albino rats.Methods: Four groups of male albino rats were used. Group I served as control. Group II rats were treated with ginger aqueous extract (24 mg/mL). Group III rats were given orally carbimazole (1.35 mg/kg bw). Group IV rats were given carbimazole and ginger extract. Animals were sacrificed and their testes were removed and stained with H&E for histological examination. Sperms were collected from epididymis for detection of sperm head abnormalities. Immunohistochemical expression of PCNA and Bax was detected in the testes.MDA, CAT and GSH were measured in the sera.Results: Treating rats with carbimazole revealed significant alterations in the tissue of testis including decreased seminiferous epithelium height, decreased diameter of seminiferous tubule and changes in the spermatogenic layers arrangement. Intertubular hemorrhage and congested blood vessels were noted. An increase in sperm head abnormalities was recorded.Decreased cell proliferation was reflected by a decrease in PCNA expression, while the increase in apoptotic rate was accompanied with an increase in Bax expression. Oxidative stress was demonstrated by an increase in malondialdehyde and decrease in activity of catalase and glutathione. Combined treatment of carbimazole and aqueous ginger extract led to an improvement in histological, morphometrical, immunohistochemical changes and oxidative stress induced by carbimazole.Conclusions: The ameliorative effects of ginger extract could be due to its antioxidant properties. 展开更多
关键词 ZINGIBER officinale carbimazole TESTIS Histology Immunohistochemistry Oxidative stress
原文传递
Selenium ameliorates carbimazole induced hepatotoxicity and oxidative stress in Albino rats
7
作者 Saber Abdel-Rahman Sakr Faten Roshdy Abdel-Ghafar Samah Mohamed Abo-El-Yazid 《Journal of Coastal Life Medicine》 2015年第2期139-145,共7页
Objective:To evaluate the effect of the antithyroid drug,carbimazole on liver of albino rats and the possible ameliorative role of selenium.Methods:Four groups of rats were used(n=10),Group 1 served as normal control,... Objective:To evaluate the effect of the antithyroid drug,carbimazole on liver of albino rats and the possible ameliorative role of selenium.Methods:Four groups of rats were used(n=10),Group 1 served as normal control,Group 2 was orally given sodium selenite(10μg/kg body weight)daily for 8 weeks,Group 3 was orally given carbimazole at a dose level of 1.35 mg/kg body weight,Group 4 was orally administered carbimazole and sodium selenite daily for 8 weeks.Rats in control and treated groups were sacrificed by cervical decapitation after 8 weeks of treatment,their livers were removed and stained with H&E for histological examinations.Alanine aminotransferase and aspartate aminotransferase were determined in the sera.Malondialdehyde and the antioxidant enzymes,catalase and superoxide dismutase were measured in the liver.Results:Cytoplasmic vacuolation of the hepatocytes,necrosis,leucocytic infiltrations,blood vessels congestion and fatty degeneration were observed in liver of carbimazole-treated animals.Carbimazole caused marked elevation in serum alanine aminotransferase and aspartate aminotransferase.It also caused an increase in malondialdehyde and depletion of the activity of the antioxidant enzymes,catalase and superoxide dismutase in the liver.Treating animals with carbimazole and selenium led to an improvement in both the histological and biochemical alterations induced by carbimazole.Moreover,selenium reduced the level of malondialdehyde and increased the activity of antioxidant enzymes,superoxide dismutase and catalase.Conclusions:It is concluded that the ameliorative effect of selenium against the hepatotoxicity of carbimazole is attributed to its antioxidant properties. 展开更多
关键词 carbimazole SELENIUM LIVER HISTOLOGY Oxidative stress
原文传递
高效液相色谱法测定卡比马唑片中卡比马唑的含量
8
作者 陈博 梁芳慧 +1 位作者 牛艳秋 董丽丹 《中外医疗》 2009年第35期91-91,171,共2页
目的建立高效液相色谱法测定卡比马唑片中卡比马唑的含量。方法反相液相色谱法。色谱柱XDB-C18,柱温40℃,甲醇∶水(80∶20)为流动相,检测波长为254nm。结果卡比马唑在0.6~6.0μg/mL的浓度范围内,线性关系良好。该方法测定卡比马唑片中... 目的建立高效液相色谱法测定卡比马唑片中卡比马唑的含量。方法反相液相色谱法。色谱柱XDB-C18,柱温40℃,甲醇∶水(80∶20)为流动相,检测波长为254nm。结果卡比马唑在0.6~6.0μg/mL的浓度范围内,线性关系良好。该方法测定卡比马唑片中卡比马唑的加样回收率为98.2%~99.8%。结论该方法简便、快速、准确、稳定,可为卡比马唑片的质量控制及完善提供科学依据。 展开更多
关键词 卡比马唑片 卡比马唑 高效液相色谱法 甲亢
下载PDF
Graves病血清可溶性白细胞介素-2受体(SIL-2R)的变化及与甲状腺自身抗体的关系
9
作者 汪新宇 李全中 +2 位作者 陈琪 翟亚萍 文世林 《山东医药》 CAS 北大核心 1999年第6期3-4,共2页
按临床表现、体征、FT3、FT4、TSH测定及治疗情况将63例Graves病患者分为未治组与治疗缓解组。用ELISA法测定血清SIL-2R。结果显示血清SIL-2R未治组与治疗缓解组相比是显著增高的(P<0.01),... 按临床表现、体征、FT3、FT4、TSH测定及治疗情况将63例Graves病患者分为未治组与治疗缓解组。用ELISA法测定血清SIL-2R。结果显示血清SIL-2R未治组与治疗缓解组相比是显著增高的(P<0.01),但治疗缓解组与正常对照组无差异。血清SIL-2R在未治组与FT3水平及甲状腺刺激抗体(TSI)、甲状腺蛋白抗体(TG-Ab)滴度呈正相关(r分别为0.678、0.580、0.730,P均<0.01)。 展开更多
关键词 GRAVES病 SIL-2R 甲状腺自身抗体
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部